Koprowski H - Search Results

1

A recombinant vaccinia-rabies virus in the immunocompromised host: oral innocuity, progressive parenteral infection, and therapeutics.

Hanlon CA, Niezgoda M, Shankar V, Niu HS, Koprowski H, Rupprecht CE. Hanlon CA, et al. Among authors: koprowski h. Vaccine. 1997 Feb;15(2):140-8. doi: 10.1016/s0264-410x(96)00163-6. Vaccine. 1997. PMID: 9066030

2

Oral vaccination of racoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein.

Fu ZF, Rupprecht CE, Dietzschold B, Saikumar P, Niu HS, Babka I, Wunner WH, Koprowski H. Fu ZF, et al. Among authors: koprowski h. Vaccine. 1993;11(9):925-8. doi: 10.1016/0264-410x(93)90379-c. Vaccine. 1993. PMID: 8212838

3

First North American field release of a vaccinia-rabies glycoprotein recombinant virus.

Hanlon CA, Niezgoda M, Hamir AN, Schumacher C, Koprowski H, Rupprecht CE. Hanlon CA, et al. Among authors: koprowski h. J Wildl Dis. 1998 Apr;34(2):228-39. doi: 10.7589/0090-3558-34.2.228. J Wildl Dis. 1998. PMID: 9577769

4

Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis.

Hanlon CA, DeMattos CA, DeMattos CC, Niezgoda M, Hooper DC, Koprowski H, Notkins A, Rupprecht CE. Hanlon CA, et al. Among authors: koprowski h. Vaccine. 2001 Jul 16;19(28-29):3834-42. doi: 10.1016/s0264-410x(01)00135-9. Vaccine. 2001. PMID: 11427255

5

Primate responses to a vaccinia-rabies glycoprotein recombinant virus vaccine.

Rupprecht CE, Hanlon CA, Cummins LB, Koprowski H. Rupprecht CE, et al. Among authors: koprowski h. Vaccine. 1992;10(6):368-74. doi: 10.1016/0264-410x(92)90065-r. Vaccine. 1992. PMID: 1598786

6

Efficacy of a vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor).

Rupprecht CE, Hamir AN, Johnston DH, Koprowski H. Rupprecht CE, et al. Among authors: koprowski h. Rev Infect Dis. 1988 Nov-Dec;10 Suppl 4:S803-9. doi: 10.1093/clinids/10.supplement_4.s803. Rev Infect Dis. 1988. PMID: 3206091

7

Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America.

Morimoto K, Patel M, Corisdeo S, Hooper DC, Fu ZF, Rupprecht CE, Koprowski H, Dietzschold B. Morimoto K, et al. Among authors: koprowski h. Proc Natl Acad Sci U S A. 1996 May 28;93(11):5653-8. doi: 10.1073/pnas.93.11.5653. Proc Natl Acad Sci U S A. 1996. PMID: 8643632 Free PMC article.

8

The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure.

Champion JM, Kean RB, Rupprecht CE, Notkins AL, Koprowski H, Dietzschold B, Hooper DC. Champion JM, et al. Among authors: koprowski h. J Immunol Methods. 2000 Feb 21;235(1-2):81-90. doi: 10.1016/s0022-1759(99)00223-9. J Immunol Methods. 2000. PMID: 10675760

9

Genotypic and phenotypic diversity of rabies virus variants involved in human rabies: implications for postexposure prophylaxis.

Dietzschold B, Morimoto K, Hooper DC, Smith JS, Rupprecht CE, Koprowski H. Dietzschold B, et al. Among authors: koprowski h. J Hum Virol. 2000 Jan-Feb;3(1):50-7. J Hum Virol. 2000. PMID: 10774807

10

Consideration of inactivated rabies vaccines as oral immunogens of wild carnivores.

Rupprecht CE, Dietzschold B, Campbell JB, Charlton KM, Koprowski H. Rupprecht CE, et al. Among authors: koprowski h. J Wildl Dis. 1992 Oct;28(4):629-35. doi: 10.7589/0090-3558-28.4.629. J Wildl Dis. 1992. PMID: 1474662

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

822 results

Search Page

Filters